UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

Videos
Event

Playback speed

10 seconds

ASH Highlights on High-Risk MDS in HMA Era: Oral HMAs, BCL2 Inhibition, Macrophage Checkpoint Inhibition, TP53 Modulators

By UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts FEATURING Olatoyosi Odenike

27 views

March 8, 2021

Comments 0

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Videos

ASH Updates on R/R MM: How to Choose Amongst Available Regimens at 1…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

B. Derman

265 views

ASH Updates on Frontline MM: What Is the Optimal Induction Regimen? …

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

B. Derman

324 views

35 y/o Male With Newly Diagnosed ALL: What Findings Are Traditionall…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

A. Duvall, P. Riedell, B. Derman, S. Kosuri

38 views

63 y/o Male With MCL: What Initial Therapy to Choose? What Would Be …

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

A. Duvall, P. Riedell, B. Derman, S. Kosuri

237 views

Newly Diagnosed MM Case Discussion: Classifying Patient Risk, and Ap…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

A. Duvall, P. Riedell, B. Derman, S. Kosuri

210 views

Expert Analysis of a Primary Myelofibrosis Case: What Tests Could Be…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

A. Duvall, P. Riedell, B. Derman, S. Kosuri

107 views

ASH Updates on Non-Malignant Hematology: Mycophenolate for ITP, CTX0…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

M. Thirman

21 views

ASH Practice Changing Updates in AML: Maintenance Oral Aza, Lower In…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

C. DiNardo

131 views

ASH Advances in Cellular Therapy: Tisa-Cel in R/R B-ALL, Blinatumoma…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

A. Jakubowiak

36 views

ASH Highlights on High-Risk MDS in HMA Era: Oral HMAs, BCL2 Inhibiti…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

O. Odenike

27 views

Best of ASH on SCT in Leukemias: Who Should Be Referred Early for AS…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

S. Kosuri

82 views

ASH Update on SCT for Myeloid and Lymphoid Leukemias: Apamistamab as…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

S. Kosuri

61 views

ASH Updates on SoC in Lymphomas: How Beneficial Are Newly Approved B…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

P. Riedell

161 views

ASH Updates on cHL: 2L Pembro + GVD, Brentuximab Vedotin & Checkpoin…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

P. Riedell

121 views

ASH Updates on SoC in R/R MCL: How Active Are Novel BTKi & CAR-T The…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

P. Riedell

29 views